Search
Close this search box.

Cybersecurity Whitepapers

Get the latest insights and information from the world of cybersecurity to help you fortify your defenses!

Lyell Immunopharma Improves Cloud Security with Fidelis Security

Lyell Immunopharma is a South San Francisco-based, publicly traded cell therapy company (LYEL). Their T cell reprogramming technology focuses on the mastery of T cells to cure patients with solid tumors. They apply proprietary genetic and epigenetic reprogramming technology platforms to address barriers present in solid tumors in order to develop new medicines with improved, durable, and potentially curative clinical outcomes.

Filter by Product:

Select
  • MITRE ATT&CK security evaluations whitepaper featured

    Fidelis Elevate: MITRE ATT&CK Security Evaluations

    Explore MITRE ATT&CK Evaluation insights with Fidelis Security's whitepaper. Understand...

    Read Whitepaper
  • Aligning Visibility for Post Breach Detection and Response with Fidelis Elevate

    Discover how to combat cyber threats effectively with Fidelis Elevate....

    Read Whitepaper
  • The Latest Trend in Network Cybersecurity: NDR

    Explore Network Detection and Response (NDR) insights in this whitepaper....

    Read Whitepaper
  • The Shared Responsibility Model: Cloud Security Unveiled

    Balancing Act: Your Role in Cloud Security Responsibilities In a...

    Read Whitepaper
  • Building cyber resilience whitepaper featured

    Building Cyber Resilience in a Threatened Landscape

    Learn how to detect and manage post-breach attacks, understand your...

    Read Whitepaper
  • Beyond Digital Transformation: Embracing Transformational Security

    Learn mindset shifts, environment understanding, platform expectations, consolidation, and more.

    Read Whitepaper
  • Mastering Active Directory Security: Strategies and Solutions

    Discover motives, tactics, and security solutions for mastering Active Directory...

    Read Whitepaper